Nix 5%

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nix 5%

Property Description
Active ingredient Permethrin
Form Cream rinse or Lotion
Pharmacological class Ectoparasiticide
General purpose Elimination of parasitic arthropods
Origin Synthetic pyrethroid

What Type of Medicine is Nix 5% Permethrin?

Nix 5% is a topical pharmaceutical preparation containing the active ingredient Permethrin, which is formally classified as an ectoparasiticide. This definition establishes the product's primary function as eliminating parasites that live on the human body surface, such as mites and lice. Permethrin is a highly effective treatment often recommended as a first-line agent for these conditions. The 5% concentration is recognized for its efficacy in managing persistent infestations when compared to standard lower-dose preparations. This difference in strength is a key differentiating factor, making the 5% formulation typically prescription-strength.


Composition, Origin, and Form: Synthetic Pyrethroid

The active component, Permethrin, is chemically defined as a synthetic pyrethroid, meaning it is manufactured but shares a similar structure with the natural pyrethrins derived from the chrysanthemum flower. The medication is delivered as a cream rinse or lotion base, which are specific types of emulsified vehicles designed for efficient cutaneous (topical) administration. The cream rinse form is a distinctive feature of the product, specifically designed to be washed out after a period of contact. Furthermore, pyrethroids like Permethrin are crucial agents in controlling arthropod populations due to their targeted effectiveness. This formulation confirms the product as a single-ingredient product, utilizing the full efficacy of the Permethrin component.


General Purpose: How Does this Ectoparasiticide Provide Benefit?

The general therapeutic purpose of this ectoparasiticide is to interrupt the life cycle of parasitic arthropods, leading to their effective elimination from the body. Permethrin achieves this by acting as a highly targeted neurotoxin that causes the rapid paralysis and death of the target organisms. For example, in a typical neutral use scenario, the product works to clear an infestation, thereby providing the direct benefit of clearing the condition and relieving the chronic irritation and discomfort associated with the presence of external parasites. This decisive action is a result of the compound’s potent effect on the arthropod nervous system.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Nix 5%?

Possible Side Effects and Safety Information

The safety profile of Nix 5% Permethrin is primarily defined by local skin reactions following topical application, which are generally mild and temporary. Regulatory documents classify adverse reactions into System-Organ Classes (SOCs), with Skin and Subcutaneous Tissue Disorders being the most frequently involved category.

Frequency Classification of Adverse Reactions

Classification Documented Reactions (Examples) Organ System
Common Burning, Stinging, Pruritus (Itching), Paraesthesia (Tingling) Skin, Nervous System
Uncommon Erythema (Redness), Rash, Numbness Skin, Nervous System

The most common effects, such as burning and stinging, are reported to be mild and transient. Less frequently documented effects include headache, dizziness, and gastrointestinal disorders like abdominal pain and nausea.

High-Level Safety Constraints

The product is contraindicated in individuals with known hypersensitivity to permethrin, synthetic pyrethroids, pyrethrins, or any component of the formulation. A key time-related safety pattern is that treatment may temporarily worsen pre-existing symptoms of the infestation. Additionally, persistent itching may continue for up to four weeks post-treatment, which regulatory notes attribute to an allergic reaction to dead parasites rather than treatment failure.

Safety and effectiveness are established only for pediatric patients two months of age and older. For infants less than two months, safety has not been established.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Nix 5% (Permethrin) is defined by two distinct exposure scenarios: accidental ingestion and excessive topical application. Systemic toxicity from applying the cream rinse or lotion in excess of the recommended amount is unlikely due to the very low rate of percutaneous absorption, which is estimated to be 2% or less. However, excessive topical use may result in localized adverse skin reactions or more severe irritation at the application site.

The primary severe exposure hazard is accidental ingestion. If the product is swallowed, regulatory guidance mandates that immediate medical help be sought by contacting a Poison Control Center or a physician. Potential systemic manifestations documented following ingestion may include nausea, vomiting, headache, dizziness, and, in rare instances, convulsion. If an individual has collapsed or is not breathing, emergency services must be contacted immediately.

Treatment for permethrin toxicity is symptomatic and supportive, as no specific antidote is listed in the regulatory documents. For accidental ingestion, gastric lavage and general supportive measures should be employed. Specific procedural guidance is provided for children, for whom gastric lavage may be considered if consultation occurs promptly following ingestion.

Therapeutic Uses of Nix 5%

What Nix 5% Treats: Main Uses and Benefits

Nix 5% is commonly used to help with the management and addressing of scabies and lice infestations, which are linked to symptoms related to inflammatory or irritative states. It is relevant for easing the presence of scabies mites or lice on the body, conditions presenting with symptomatic manifestations.


Symptom Relief and Comfort

The medication is relevant for easing symptom clusters that may become intense or disruptive, particularly the severe, persistent itching (pruritus) that is characteristic of these conditions, along with the associated redness and rash. It assists with managing symptoms related to inflammatory or irritative states where temporary functional strain or discomfort is present. This treatment provides support that helps ease the overall symptom burden during periods of heightened symptoms.

Used in settings where short-term symptomatic assistance is needed to resolve acute manifestations, Nix 5% assists with maintaining functional stability and general well-being. The overall goal is to support patients during difficult episodes, as “it may assist with maintaining functional stability.”

Quick Fact: Relevant for Easing Intense Itching

Regulatory References

  1. National Library of Medicine MedlinePlus Drug Information

Eligibility and Restrictions for Use

The official eligibility profile for Nix 5% (Permethrin 5% cream) is strictly defined by regulatory authorities based on patient population, age, and known sensitivities.

Category Eligibility Status (Official Labeling)
Absolute Contraindications Hypersensitivity to Permethrin, synthetic pyrethroids, pyrethrins, or any formulation component. Infants less than two months of age (safety not established).
Specific Allergy Restriction Patients with known ragweed or Asteraceae family plant allergies are restricted due to the official risk of an asthmatic reaction.
Approved Age Group Established as safe and effective for patients two months of age and older, including adolescents and adults.
Pregnancy Status Classified as Pregnancy Category B; use is conditional and permitted only if clearly needed due to a lack of adequate human studies.
Lactation Status Nursing mothers should consider temporarily discontinuing breastfeeding as it is not known if the drug is excreted in human milk.

This regulatory framework strictly defines non-eligibility through absolute contraindications related to known allergic history and the minimum age threshold. Use is prohibited in infants under two months because safety and effectiveness are officially not established. Outside of these restrictions, use is generally allowed for eligible age groups, with specific conditional requirements placed on pregnant and nursing populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Nix 5% is defined by minimal systemic interaction potential due to its topical administration. Regulatory documents state that no systemic drug interactions are known for this medicine. The active ingredient, Permethrin, is absorbed in extremely low amounts (less than 1%) and is rapidly metabolized by esterases, which severely limits the potential for clinically significant interactions involving drug-metabolizing enzymes.

Interaction Scope Official Regulatory Statement
Pharmacokinetic Potential No known systemic drug interactions.
Food, Alcohol, Herbal Products No known interactions documented in regulatory labels.

Pharmacodynamic Interaction and Restriction

A specific pharmacodynamic constraint exists regarding the use of topical corticosteroids:

Classification Aspect Regulatory Statement
Interacting Category Topical Corticosteroids (used for eczematous reactions)
Interaction Mechanism Additive pharmacodynamic effect that may exacerbate the primary infestation by reducing the host’s local immune response to the parasite.
Timing Requirement Treatment with topical corticosteroids for associated reactions must be withheld prior to initiating Permethrin application.

The overall interaction structure is characterized by a high degree of specificity, focusing almost entirely on this single required timing separation to ensure the efficacy of the anti-parasitic treatment.

Mechanism of Action

The mechanism of Nix 5% (Permethrin) is defined by its neurotoxic action on the nervous systems of parasitic arthropods, leading to physiological failure. The active ingredient binds directly to the voltage-gated sodium channels within the neuronal membranes of the mites and lice, functioning as a channel inhibitor. This action prevents the channels from undergoing proper inactivation and closure, causing a persistent influx of sodium ions ( Na^+). The sustained ion influx disrupts the nerve cell potential, resulting in uncontrolled electrical activity, a state called neurotoxic hyperexcitation. This continuous firing of nerve impulses rapidly cascades into systemic failure, culminating in irreversible muscular and respiratory paralysis, which is the core physiological consequence of the mechanistic cascade. The mechanism is highly selective for arthropods but is functionally limited by its lack of ovicidal activity (the mechanism does not disrupt the egg stage) and can be weakened by target resistance (genetic mutations in the sodium channel).

Dosage and Administration Information

The use of Permethrin 5% cream is a standardized, single-course topical application intended for external use only. The medication must not be ingested or applied to mucous membranes.

Administration Procedure and Dosage

For adults and children 2 months of age and older, the cream is administered as a single, time-limited course. The typical adult dose required for full body coverage is up to 30 grams, although larger individuals may require up to 60 grams (two tubes) for a complete application.

Application and Duration

Application involves thoroughly massaging the cream into all skin surfaces. For most individuals over the age of two, this covers the entire body from the neck down to the soles of the feet. Once applied, the cream must be left on the skin for a period of 8 to 14 hours before being thoroughly removed by showering or bathing. Reapplication to the hands is required if they are washed within this leave-on period.

Population-Specific Use

For infants (2 months to 2 years of age) and older adults (over 65 years), the application protocol is modified. The cream must also include the scalp, hairline, face, and ears to ensure comprehensive coverage, which is a key variation from the standard adult application. Use in infants under two months of age has not been established. A second application may be considered only if live mites or new lesions are detected 7 to 14 days after the initial treatment.

Recent Clinical Evidence

Research evidence / Overview of Studies for Nix 5%


Evidence for Use in Scabies Infestation

The principal body of clinical evidence for Permethrin 5% focuses on its evaluation in the context of scabies infestation. This research primarily relies on Randomized Controlled Trials (RCTs), where the compound was evaluated against a placebo or against other established topical compounds in the study of scabies. Researchers used these studies to monitor key outcomes related to the measured elimination of organisms, such as the Sarcoptes scabiei mite, its eggs, and feces. Studies also monitored symptom patterns related to physical discomfort, such as the severity and duration of persistent itching (pruritus).

Systematic reviews and meta-analyses describe the patterns measured in trials related to the measured elimination of organisms at follow-up points usually within a few weeks after application. Comparative evidence derived from these settings reported patterns related to the measured elimination of organisms when this compound was evaluated against other established topical compounds.


Evidence for Use in Head Lice Infestation

Permethrin, the active ingredient in the 5% formulation, was also studied in the context of head lice. Research for the active compound in the context of Pediculosis capitis largely consists of comparative RCTs that examined topical agents. These studies primarily monitored outcomes related to the short-term goal of measured organism-free status at defined follow-up intervals, typically one to two weeks after application. They also monitored outcomes related to the measured non-viability of nits (eggs).

The majority of research for head lice has traditionally explored the lower (1%) concentration of the compound. Consequently, the evidence base for the 5% concentration specifically in this context is limited when compared to the research available for scabies.


Documented Evidence Gaps and Uncertainties

Scientific reviews have highlighted several structural limitations within the research base. Follow-up durations were limited for fully characterizing long-term recurrence rates. Evidence quality varies across studies, and the findings related to initial elimination may not translate uniformly due to the potential for mite resistance in certain locations. Scientific research has also noted the difficulty in differentiating between recurrence and the duration of post-treatment symptoms in observational settings.

Key Studies & References

  1. Permethrin Versus Benzyl Benzoate for the Treatment of Scabies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  2. Label: PERMETHRIN cream 5% w/w cream (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Nix 5% (FAQ)


Q: What is the main difference between Nix 5% cream and the 1% lotion/shampoo products?

A: Official information from government health bodies and product labeling clarifies that the difference lies in both strength and primary approved use. The 5% cream is approved and typically prescription-strength for treating scabies, which requires a full-body application. In contrast, the lower-strength 1% lotion/rinse is generally available over-the-counter (OTC) and is approved for treating head lice, applied only to the hair and scalp for a much shorter duration.


Q: Are there specific excipients (inactive ingredients) in Nix 5% that can cause local skin reactions?

A: The official labeling, such as that provided by the FDA, lists the product's full composition, which includes inactive ingredients. Patients with specific sensitivities are advised to be aware that the cream contains substances such as butylated hydroxytoluene and trace amounts of formaldehyde, among others. These excipients may be a potential concern for individuals with known allergies to these specific components.


Q: Does the application of Nix 5% require the use of protective gloves for the person applying it?

A: Guidance from several health bodies indicates that disposable gloves are often recommended for the individual applying the cream to the patient, particularly when covering large areas. This is suggested to help avoid unnecessary contact with the chemical, and the gloves are typically recommended to be removed immediately after the procedure.


Q: Why is it important to pay attention to areas like between the fingers and toes during application?

A: Regulatory guidelines emphasize the need for comprehensive coverage of all skin surfaces from the neck down when applying the cream. This includes areas of skin folds, such as behind the knees, and sites like between the fingers and toes. These specific areas are noted because they can be easily missed during application, which may allow parasites to survive incomplete treatment.


Q: What should be done if Nix 5% accidentally gets into the eyes or mouth?

A: As the product is for external use only, official patient information indicates that if the cream enters the eyes, immediate flushing with large amounts of water is the suggested step. If the product is ingested (mouth) or if irritation persists, regulatory documents advise seeking medical attention. It is important to keep the product away from mucous membranes.


Q: Why is Nix 5% sometimes thought to be ineffective by users?

A: Official safety notes indicate that persistent itching can continue for up to four weeks after treatment, which is often attributed to an allergic reaction to dead parasites and is not necessarily a sign of treatment failure. Additionally, the product label notes that the treatment may temporarily worsen pre-existing symptoms of the infestation, which can sometimes be misinterpreted by users as a lack of efficacy.


Q: What is the typical timeframe for Nix 5% to start working after application?

A: The drug's mechanism of action involves rapid action on the nervous systems of the parasites, leading to paralysis. The official protocol, however, requires the cream to remain on the skin for the full 8 to 14 hours as a contact time to achieve the intended full therapeutic effect. Live organisms may still be present after this period if the eggs hatch, which is why a second application may be considered.


Q: What are common reasons for treatment failure with Nix 5%?

A: Known factors that contribute to treatment failure are documented in medical literature and regulatory documents. These include the drug's lack of ovicidal activity (meaning it does not kill the eggs), the development of drug resistance in parasite populations, and inadequate application technique (e.g., missing skin surfaces). A second application may be needed if live organisms are detected after the initial course.


Q: How does resistance to Permethrin 5% (the active ingredient) occur in parasites?

A: The mechanism of resistance, often referred to as knockdown resistance or kdr, is typically the result of genetic mutations occurring in the parasite's nerve cells. These mutations specifically affect the parasite's voltage-gated sodium channels. This change makes the nervous system less sensitive to the active ingredient's chemical action, which ultimately reduces the intended paralyzing effect.


Q: Is it true that Nix 5% can cause dry skin or temporary skin numbness?

A: The side effects profile lists paraesthesia, which is a sensation of temporary numbness, burning, or tingling, as a common reaction following application. Furthermore, skin dryness (known technically as xeroderma) is also listed in some official adverse effect profiles. These effects are typically mild and transient.


Q: What kind of allergic reactions or severe side effects are officially associated with Nix 5%?

A: The most common reactions are mild and local, such as stinging or burning on the skin. Official regulatory warnings highlight that severe side effects, though rare, can include systemic allergic reactions such as difficulty breathing or an asthmatic attack, particularly in patients with known allergies to ragweed or other Asteraceae plants. The product is strictly contraindicated for anyone with known hypersensitivity to its components.


Q: Can Nix 5% worsen symptoms of existing skin conditions like asthma or eczema?

A: Official guidance notes that the use of topical corticosteroids for reactions like eczema just prior to or during treatment can potentially exacerbate the primary infestation by reducing the body's local immune response. Additionally, for patients with specific plant allergies, the label cautions about the potential risk of an asthmatic reaction due to components related to natural pyrethrins.


Q: Is it necessary to treat all family members or close contacts at the same time?

A: Many medical guidelines indicate that simultaneous treatment is generally recommended for close contacts who live in the same household or have had prolonged skin-to-skin contact with the affected patient. This is cited as a standard protocol to reduce the risk of re-infestation.


Q: Why do official guidelines suggest treating household contacts even if they don't have symptoms?

A: Official guidance suggests simultaneous treatment because the infestation can spread through close physical contact before symptoms or visible signs of the parasite appear. The goal of treating contacts at the same time is to support the initial treatment protocol by reducing the risk of re-infestation from an undiagnosed source.


Q: What general cleaning or decontamination procedures for clothing and bedding are suggested after using Nix 5%?

A: Authoritative guidelines describe that clothing, towels, and bedding used in the days leading up to treatment are recommended to be washed in hot water (e.g., above 60 C) and dried using a hot cycle. Alternatively, items can be sealed in a plastic bag for at least 72 hours. This is intended to destroy any parasites that may have been shed.


Q: Is it necessary to treat pets, furniture, or the entire house when using Nix 5%?

A: For the conditions Nix 5% is approved to treat, routine environmental fumigation or treating pets is generally not necessary. Official guidance states that the target parasites do not typically survive more than a few days away from a human host. Decontamination efforts are typically limited to washing clothing/bedding or using specialized sprays only on items like mattresses or upholstered furniture that cannot be laundered.


Q: Are there any published concerns about the environmental impact of Nix 5%?

A: Yes, due to environmental concerns, official disposal instructions state that the product is not to be poured down a sink, toilet, or any drain. Unwanted product is recommended to be disposed of via an approved drug take-back program or mixed with an unappealing substance and sealed before being placed in household trash.


Q: Is Nix 5% available over-the-counter (OTC) or only by prescription?

A: According to official product documentation and availability status, the 5% cream formulation used for treating scabies is prescription-only. It is the lower-strength 1% lotion used for treating head lice that is typically available over-the-counter (OTC).


Q: What is the difference in treatment protocols for the 5% cream vs. the 1% lotion if used for lice?

A: The 5% cream is intended for the full-body, 8–14 hour application protocol used to treat scabies. In contrast, the 1% lotion/rinse product for head lice is applied only to the hair and scalp for a much shorter duration, typically 10 minutes, followed by rinsing. These protocols are based on the drug’s different approved uses.


Q: Do studies suggest Nix 5% is effective for other types of insect bites or infestations?

A: The drug is formally classified as an ectoparasiticide, and its specific mechanism of action is generally effective against a broad range of parasitic arthropods. However, regulatory approval and the primary body of clinical research supporting the product's use are focused specifically on its labeled conditions (scabies and head lice).

How should Nix 5% be stored and disposed of?

How to Store and Dispose of Nix 5% Permethrin Cream

Official regulatory guidelines mandate specific conditions for storing Nix 5% to maintain its stability. The product must be stored at Controlled Room Temperature, defined as 20 to 25 C (68 to 77 F). It is required to keep the cream in its original container with the cap tightly closed, and it must not be frozen.

For safety, the medication must be stored out of the reach of children.

Disposal Requirement Official Regulatory Instruction
Preferred Method Use a drug take-back program.
Alternative Method Mix with an unappealing substance (e.g., dirt) in a sealed bag before placing in household trash.
Environmental Rule Do not pour the product down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nix 5% found in:

A-Z Index: